Loading...
Mettler-Toledo International Inc.
0K10.L•LSE
Healthcare
Medical - Pharmaceuticals
£1171.16
£-23.84(-1.99%)
Mettler-Toledo International Inc. (0K10.L) Financial Performance & Statements
Review Mettler-Toledo International Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
2.22%
↑ 2.22%
Operating Income Growth
-2.16%
↓ 2.16%
Net Income Growth
9.43%
↑ 9.43%
Operating Cash Flow Growth
0.26%
↑ 0.26%
Operating Margin
29.15%
↑ 29.15%
Gross Margin
58.17%
↑ 58.17%
Net Profit Margin
22.29%
↑ 22.29%
ROE
-582.49%
↓ 582.49%
ROIC
54.49%
↑ 54.49%
Mettler-Toledo International Inc. (0K10.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Mettler-Toledo International Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.05B | $954.53M | $946.75M | $925.95M |
| Cost of Revenue | $405.81M | $382.07M | $399.26M | $396.04M |
| Gross Profit | $639.32M | $572.47M | $547.49M | $529.90M |
| Gross Profit Ratio | $0.61 | $0.60 | $0.58 | $0.57 |
| R&D Expenses | $50.05M | $47.12M | $45.77M | $46.41M |
| SG&A Expenses | $237.34M | $228.78M | $235.80M | $234.39M |
| Operating Expenses | $287.39M | $275.89M | $281.57M | $280.81M |
| Total Costs & Expenses | $693.21M | $657.96M | $680.83M | $676.85M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $17.85M | $18.60M | $18.95M | $19.23M |
| Depreciation & Amortization | $30.86M | $31.08M | $30.53M | $30.75M |
| EBITDA | $363.26M | $308.63M | $295.76M | $279.85M |
| EBITDA Ratio | $0.35 | $0.32 | $0.31 | $0.30 |
| Operating Income | $333.70M | $332.98M | $265.92M | $249.10M |
| Operating Income Ratio | $0.32 | $0.35 | $0.28 | $0.27 |
| Other Income/Expenses (Net) | -$19.15M | -$74.03M | -$22.75M | -$48.78M |
| Income Before Tax | $314.55M | $258.95M | $243.18M | $220.55M |
| Income Before Tax Ratio | $0.30 | $0.27 | $0.26 | $0.24 |
| Income Tax Expense | $62.25M | $47.44M | $21.36M | $43.04M |
| Net Income | $252.30M | $211.52M | $221.81M | $177.51M |
| Net Income Ratio | $0.24 | $0.22 | $0.23 | $0.19 |
| EPS | $12.00 | $9.94 | $10.42 | $8.28 |
| Diluted EPS | $11.96 | $9.94 | $10.37 | $8.24 |
| Weighted Avg Shares Outstanding | $21.02M | $21.29M | $21.28M | $21.44M |
| Weighted Avg Shares Outstanding (Diluted) | $21.10M | $21.29M | $21.39M | $21.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan